Christopher Gignoux
Concepts (395)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetics, Population | 33 | 2025 | 210 | 3.340 |
Why?
| | Genome-Wide Association Study | 42 | 2025 | 1434 | 2.200 |
Why?
| | Polymorphism, Single Nucleotide | 55 | 2025 | 2195 | 2.090 |
Why?
| | Genome, Human | 25 | 2025 | 425 | 1.930 |
Why?
| | Genetic Variation | 18 | 2025 | 988 | 1.720 |
Why?
| | Genetic Predisposition to Disease | 26 | 2025 | 2419 | 1.420 |
Why?
| | Genomics | 19 | 2025 | 792 | 1.220 |
Why?
| | Models, Genetic | 12 | 2025 | 607 | 1.190 |
Why?
| | Multifactorial Inheritance | 11 | 2025 | 174 | 1.040 |
Why?
| | Precision Medicine | 4 | 2024 | 428 | 0.970 |
Why?
| | Asthma | 19 | 2019 | 2293 | 0.970 |
Why?
| | Haplotypes | 23 | 2025 | 493 | 0.950 |
Why?
| | Genetics, Medical | 5 | 2023 | 26 | 0.910 |
Why?
| | Biological Specimen Banks | 5 | 2024 | 102 | 0.780 |
Why?
| | Pharmacogenetics | 2 | 2021 | 179 | 0.780 |
Why?
| | Transcriptome | 5 | 2024 | 972 | 0.770 |
Why?
| | Gastritis | 1 | 2023 | 108 | 0.750 |
Why?
| | Enteritis | 1 | 2023 | 103 | 0.740 |
Why?
| | Desogestrel | 1 | 2021 | 46 | 0.700 |
Why?
| | Human Migration | 6 | 2021 | 23 | 0.640 |
Why?
| | Gene Flow | 8 | 2020 | 83 | 0.610 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2018 | 10 | 0.600 |
Why?
| | Humans | 130 | 2025 | 137294 | 0.600 |
Why?
| | Smad2 Protein | 1 | 2018 | 38 | 0.600 |
Why?
| | Eosinophilic Esophagitis | 1 | 2023 | 325 | 0.590 |
Why?
| | Genotype | 24 | 2025 | 1923 | 0.580 |
Why?
| | Gene Frequency | 13 | 2025 | 521 | 0.580 |
Why?
| | Pedigree | 4 | 2025 | 514 | 0.550 |
Why?
| | Chromosome Mapping | 11 | 2023 | 524 | 0.480 |
Why?
| | Population | 2 | 2014 | 35 | 0.470 |
Why?
| | Population Growth | 2 | 2012 | 9 | 0.460 |
Why?
| | DNA, Mitochondrial | 6 | 2016 | 200 | 0.460 |
Why?
| | Metagenomics | 4 | 2023 | 167 | 0.440 |
Why?
| | DNA Methylation | 4 | 2025 | 644 | 0.430 |
Why?
| | Indians, North American | 7 | 2021 | 630 | 0.420 |
Why?
| | Receptors, KIR | 5 | 2022 | 98 | 0.420 |
Why?
| | Mexican Americans | 7 | 2023 | 120 | 0.410 |
Why?
| | Agriculture | 2 | 2011 | 101 | 0.400 |
Why?
| | Evolution, Molecular | 6 | 2021 | 488 | 0.400 |
Why?
| | Genetic Loci | 7 | 2019 | 289 | 0.370 |
Why?
| | Exome | 5 | 2022 | 231 | 0.370 |
Why?
| | Phenotype | 14 | 2025 | 3202 | 0.340 |
Why?
| | Molecular Epidemiology | 3 | 2023 | 67 | 0.340 |
Why?
| | Alleles | 12 | 2025 | 892 | 0.340 |
Why?
| | Quantitative Trait Loci | 6 | 2024 | 382 | 0.340 |
Why?
| | Indians, South American | 2 | 2020 | 25 | 0.340 |
Why?
| | Genetic Association Studies | 3 | 2022 | 377 | 0.320 |
Why?
| | Computational Biology | 3 | 2023 | 646 | 0.310 |
Why?
| | Population Groups | 2 | 2020 | 62 | 0.310 |
Why?
| | Linkage Disequilibrium | 9 | 2023 | 269 | 0.300 |
Why?
| | Female | 50 | 2025 | 73052 | 0.300 |
Why?
| | Proteome | 2 | 2024 | 472 | 0.290 |
Why?
| | Kidney Diseases | 2 | 2025 | 406 | 0.290 |
Why?
| | Skin Pigmentation | 2 | 2018 | 49 | 0.290 |
Why?
| | Selection, Genetic | 4 | 2019 | 263 | 0.280 |
Why?
| | Receptors, KIR2DL1 | 2 | 2018 | 19 | 0.270 |
Why?
| | Gene-Environment Interaction | 3 | 2023 | 194 | 0.260 |
Why?
| | Epigenesis, Genetic | 4 | 2025 | 659 | 0.260 |
Why?
| | Genetic Markers | 7 | 2023 | 344 | 0.260 |
Why?
| | Mexico | 8 | 2023 | 225 | 0.260 |
Why?
| | Male | 47 | 2025 | 67560 | 0.250 |
Why?
| | Phylogeography | 5 | 2020 | 54 | 0.250 |
Why?
| | Environmental Exposure | 3 | 2017 | 577 | 0.250 |
Why?
| | Colorado | 4 | 2024 | 4527 | 0.250 |
Why?
| | Minority Groups | 2 | 2019 | 267 | 0.240 |
Why?
| | Risk Factors | 17 | 2025 | 10368 | 0.240 |
Why?
| | Obesity | 3 | 2025 | 2983 | 0.240 |
Why?
| | Delivery of Health Care | 2 | 2023 | 944 | 0.230 |
Why?
| | Algorithms | 4 | 2025 | 1692 | 0.230 |
Why?
| | Phylogeny | 7 | 2022 | 900 | 0.230 |
Why?
| | Puerto Rico | 8 | 2021 | 53 | 0.220 |
Why?
| | Killer Cells, Natural | 4 | 2021 | 445 | 0.220 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1774 | 0.220 |
Why?
| | Bivalvia | 1 | 2024 | 8 | 0.220 |
Why?
| | Heterozygote | 3 | 2021 | 292 | 0.220 |
Why?
| | Longevity | 1 | 2025 | 165 | 0.210 |
Why?
| | Chromosomes, Human, Pair 6 | 3 | 2014 | 54 | 0.210 |
Why?
| | Genes, MHC Class I | 2 | 2021 | 35 | 0.210 |
Why?
| | Thyroid Nodule | 1 | 2024 | 56 | 0.210 |
Why?
| | Long QT Syndrome | 1 | 2024 | 70 | 0.200 |
Why?
| | Young Adult | 12 | 2022 | 13163 | 0.200 |
Why?
| | Glaucoma, Open-Angle | 1 | 2024 | 103 | 0.190 |
Why?
| | Receptors, KIR3DS1 | 1 | 2022 | 6 | 0.190 |
Why?
| | Proteins | 2 | 2022 | 1012 | 0.190 |
Why?
| | Receptors, KIR3DL1 | 1 | 2022 | 18 | 0.190 |
Why?
| | Software | 2 | 2025 | 667 | 0.190 |
Why?
| | Emigration and Immigration | 3 | 2013 | 49 | 0.190 |
Why?
| | Case-Control Studies | 10 | 2024 | 3546 | 0.190 |
Why?
| | Immunoglobulin E | 2 | 2014 | 342 | 0.190 |
Why?
| | Myocardial Ischemia | 1 | 2023 | 263 | 0.180 |
Why?
| | Demography | 5 | 2018 | 291 | 0.180 |
Why?
| | C-Reactive Protein | 1 | 2024 | 412 | 0.180 |
Why?
| | Obesity, Morbid | 1 | 2025 | 259 | 0.180 |
Why?
| | Jews | 1 | 2021 | 23 | 0.180 |
Why?
| | Collagen Type VII | 1 | 2021 | 28 | 0.180 |
Why?
| | Computer Simulation | 6 | 2025 | 979 | 0.180 |
Why?
| | Pharmacogenomic Variants | 1 | 2021 | 35 | 0.180 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 2113 | 0.180 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2021 | 41 | 0.180 |
Why?
| | Uterine Hemorrhage | 1 | 2021 | 33 | 0.180 |
Why?
| | History, Medieval | 3 | 2021 | 47 | 0.180 |
Why?
| | Electrocardiography | 1 | 2024 | 630 | 0.170 |
Why?
| | Drug Implants | 1 | 2021 | 82 | 0.170 |
Why?
| | Interleukin-6 | 1 | 2025 | 778 | 0.170 |
Why?
| | Indians, Central American | 1 | 2020 | 6 | 0.170 |
Why?
| | Eosinophilia | 1 | 2023 | 218 | 0.170 |
Why?
| | Latin America | 2 | 2018 | 95 | 0.170 |
Why?
| | Adiposity | 1 | 2025 | 518 | 0.170 |
Why?
| | Population Health | 1 | 2021 | 47 | 0.170 |
Why?
| | Adolescent | 18 | 2021 | 21499 | 0.170 |
Why?
| | Reference Standards | 1 | 2020 | 186 | 0.160 |
Why?
| | Self Report | 2 | 2021 | 826 | 0.160 |
Why?
| | Pre-Eclampsia | 1 | 2022 | 189 | 0.160 |
Why?
| | Adaptation, Biological | 1 | 2020 | 56 | 0.160 |
Why?
| | Thyroid Neoplasms | 1 | 2024 | 337 | 0.160 |
Why?
| | Lipase | 1 | 2020 | 69 | 0.160 |
Why?
| | Aged | 12 | 2025 | 23851 | 0.160 |
Why?
| | Human Genetics | 1 | 2019 | 3 | 0.160 |
Why?
| | Triglycerides | 2 | 2023 | 524 | 0.160 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 363 | 0.160 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2024 | 2516 | 0.160 |
Why?
| | Apolipoprotein L1 | 1 | 2018 | 13 | 0.150 |
Why?
| | Adult | 18 | 2025 | 37724 | 0.150 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 352 | 0.150 |
Why?
| | Geographic Mapping | 1 | 2019 | 23 | 0.150 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2017 | 767 | 0.150 |
Why?
| | Antiporters | 1 | 2018 | 22 | 0.150 |
Why?
| | Liver Diseases | 1 | 2021 | 311 | 0.150 |
Why?
| | Europe | 5 | 2020 | 414 | 0.150 |
Why?
| | Coronary Artery Disease | 2 | 2023 | 703 | 0.150 |
Why?
| | Chromosomes, Human, Y | 2 | 2008 | 24 | 0.140 |
Why?
| | HLA-C Antigens | 1 | 2018 | 35 | 0.140 |
Why?
| | Primates | 1 | 2019 | 125 | 0.140 |
Why?
| | Collagen Diseases | 1 | 2017 | 6 | 0.140 |
Why?
| | Fibrillar Collagens | 1 | 2017 | 14 | 0.140 |
Why?
| | Atherosclerosis | 1 | 2022 | 415 | 0.140 |
Why?
| | Dermatitis, Atopic | 1 | 2021 | 329 | 0.140 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 71 | 0.140 |
Why?
| | United States | 15 | 2021 | 14742 | 0.140 |
Why?
| | Weight Gain | 1 | 2021 | 519 | 0.140 |
Why?
| | Microbiota | 2 | 2023 | 761 | 0.140 |
Why?
| | Apolipoprotein A-V | 1 | 2017 | 3 | 0.140 |
Why?
| | Gene Pool | 2 | 2013 | 5 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2021 | 949 | 0.130 |
Why?
| | History, Ancient | 3 | 2013 | 54 | 0.130 |
Why?
| | Inflammation | 2 | 2025 | 2836 | 0.130 |
Why?
| | Kidney | 1 | 2025 | 1467 | 0.130 |
Why?
| | Saliva | 2 | 2020 | 244 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 1 | 2023 | 808 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 279 | 0.130 |
Why?
| | Homozygote | 3 | 2023 | 203 | 0.130 |
Why?
| | Women's Health | 1 | 2019 | 370 | 0.130 |
Why?
| | Language | 2 | 2011 | 298 | 0.130 |
Why?
| | Middle Aged | 14 | 2025 | 33310 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 793 | 0.120 |
Why?
| | Colombia | 3 | 2021 | 41 | 0.120 |
Why?
| | Research Design | 1 | 2022 | 1128 | 0.120 |
Why?
| | Social Class | 2 | 2013 | 281 | 0.110 |
Why?
| | CpG Islands | 2 | 2025 | 159 | 0.110 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 5 | 0.110 |
Why?
| | Premature Birth | 1 | 2018 | 331 | 0.110 |
Why?
| | Africa, Southern | 3 | 2018 | 8 | 0.110 |
Why?
| | Minority Health | 1 | 2013 | 20 | 0.110 |
Why?
| | Ikaros Transcription Factor | 1 | 2014 | 24 | 0.110 |
Why?
| | Health Surveys | 1 | 2016 | 517 | 0.110 |
Why?
| | Population Dynamics | 2 | 2012 | 149 | 0.110 |
Why?
| | Urban Health | 1 | 2013 | 92 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1623 | 0.100 |
Why?
| | Search Engine | 1 | 2013 | 12 | 0.100 |
Why?
| | Emigrants and Immigrants | 1 | 2016 | 139 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2020 | 1163 | 0.100 |
Why?
| | Kv Channel-Interacting Proteins | 1 | 2013 | 3 | 0.100 |
Why?
| | Nasal Mucosa | 1 | 2014 | 107 | 0.100 |
Why?
| | Hypersensitivity, Immediate | 1 | 2013 | 44 | 0.100 |
Why?
| | Albuterol | 1 | 2013 | 110 | 0.100 |
Why?
| | Neanderthals | 1 | 2013 | 13 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 424 | 0.100 |
Why?
| | Child | 15 | 2020 | 21999 | 0.100 |
Why?
| | Chromosomes, Human, Pair 19 | 1 | 2012 | 25 | 0.100 |
Why?
| | Kallikreins | 1 | 2012 | 29 | 0.100 |
Why?
| | Principal Component Analysis | 1 | 2013 | 195 | 0.100 |
Why?
| | HLA-DQ beta-Chains | 1 | 2012 | 63 | 0.100 |
Why?
| | Forced Expiratory Volume | 2 | 2013 | 532 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 769 | 0.100 |
Why?
| | Mutation | 5 | 2018 | 3956 | 0.100 |
Why?
| | Air Pollution | 1 | 2016 | 315 | 0.100 |
Why?
| | Biological Evolution | 2 | 2019 | 465 | 0.090 |
Why?
| | Respiratory Function Tests | 2 | 2012 | 596 | 0.090 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 248 | 0.090 |
Why?
| | Prostate-Specific Antigen | 1 | 2012 | 161 | 0.090 |
Why?
| | United Kingdom | 2 | 2023 | 315 | 0.090 |
Why?
| | HLA-B Antigens | 2 | 2022 | 62 | 0.090 |
Why?
| | Tuberculosis | 1 | 2014 | 279 | 0.090 |
Why?
| | History, 17th Century | 1 | 2011 | 16 | 0.090 |
Why?
| | History, 15th Century | 1 | 2011 | 12 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2014 | 312 | 0.090 |
Why?
| | Polynesia | 2 | 2021 | 4 | 0.090 |
Why?
| | History, 18th Century | 1 | 2011 | 19 | 0.090 |
Why?
| | Cluster Analysis | 3 | 2023 | 497 | 0.090 |
Why?
| | Lung | 2 | 2016 | 4067 | 0.090 |
Why?
| | History, 19th Century | 1 | 2011 | 60 | 0.090 |
Why?
| | Anthropometry | 2 | 2025 | 213 | 0.090 |
Why?
| | Chile | 2 | 2021 | 24 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5436 | 0.090 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2243 | 0.090 |
Why?
| | Respiratory Sounds | 1 | 2011 | 124 | 0.090 |
Why?
| | Body Height | 2 | 2023 | 199 | 0.090 |
Why?
| | Estrogen Receptor alpha | 1 | 2012 | 145 | 0.080 |
Why?
| | Body Mass Index | 3 | 2025 | 2373 | 0.080 |
Why?
| | History, 21st Century | 1 | 2011 | 212 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 284 | 0.080 |
Why?
| | Databases, Genetic | 2 | 2021 | 237 | 0.080 |
Why?
| | South Africa | 3 | 2015 | 219 | 0.080 |
Why?
| | History, 20th Century | 1 | 2011 | 324 | 0.080 |
Why?
| | Genotyping Techniques | 2 | 2020 | 75 | 0.080 |
Why?
| | Peru | 2 | 2022 | 59 | 0.080 |
Why?
| | Vital Capacity | 1 | 2010 | 309 | 0.080 |
Why?
| | Electronic Health Records | 3 | 2021 | 1045 | 0.080 |
Why?
| | Chromosomes, Human, Pair 8 | 2 | 2019 | 36 | 0.070 |
Why?
| | Africa | 3 | 2017 | 108 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1399 | 0.070 |
Why?
| | South America | 2 | 2020 | 59 | 0.070 |
Why?
| | Americas | 2 | 2018 | 28 | 0.070 |
Why?
| | Life Style | 2 | 2022 | 488 | 0.070 |
Why?
| | Signal Transduction | 2 | 2019 | 5078 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1042 | 0.070 |
Why?
| | Risk | 3 | 2018 | 908 | 0.070 |
Why?
| | Ants | 1 | 2007 | 25 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2024 | 401 | 0.070 |
Why?
| | Linguistics | 1 | 2007 | 29 | 0.070 |
Why?
| | Odds Ratio | 3 | 2014 | 1067 | 0.070 |
Why?
| | Whole Genome Sequencing | 2 | 2018 | 153 | 0.070 |
Why?
| | Chromosomes, Human, Pair 17 | 2 | 2019 | 55 | 0.070 |
Why?
| | Speech | 1 | 2007 | 73 | 0.070 |
Why?
| | Human Genome Project | 2 | 2017 | 15 | 0.060 |
Why?
| | Lung Diseases | 1 | 2012 | 769 | 0.060 |
Why?
| | Cytokine Receptor gp130 | 1 | 2025 | 12 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3710 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 1 | 2025 | 43 | 0.060 |
Why?
| | Bias | 2 | 2019 | 218 | 0.060 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 537 | 0.060 |
Why?
| | Base Sequence | 3 | 2016 | 2182 | 0.060 |
Why?
| | Body Size | 1 | 2025 | 108 | 0.060 |
Why?
| | RNA | 1 | 2011 | 924 | 0.060 |
Why?
| | Child, Preschool | 6 | 2020 | 11080 | 0.060 |
Why?
| | Phenethylamines | 1 | 2024 | 23 | 0.060 |
Why?
| | Torsades de Pointes | 1 | 2024 | 24 | 0.060 |
Why?
| | Argentina | 2 | 2015 | 26 | 0.060 |
Why?
| | Microsatellite Repeats | 3 | 2011 | 168 | 0.050 |
Why?
| | Cohort Studies | 4 | 2019 | 5726 | 0.050 |
Why?
| | Polymorphism, Genetic | 2 | 2018 | 658 | 0.050 |
Why?
| | Iran | 1 | 2023 | 42 | 0.050 |
Why?
| | Los Angeles | 1 | 2023 | 76 | 0.050 |
Why?
| | Geography | 2 | 2016 | 198 | 0.050 |
Why?
| | Biology | 1 | 2024 | 87 | 0.050 |
Why?
| | Caribbean Region | 2 | 2013 | 26 | 0.050 |
Why?
| | Lipoprotein(a) | 1 | 2023 | 67 | 0.050 |
Why?
| | Minisatellite Repeats | 1 | 2002 | 42 | 0.050 |
Why?
| | Factor X | 1 | 2022 | 27 | 0.050 |
Why?
| | Factor VII | 1 | 2022 | 24 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 309 | 0.050 |
Why?
| | Genes | 1 | 2002 | 230 | 0.050 |
Why?
| | Blood Coagulation Factors | 1 | 2022 | 54 | 0.050 |
Why?
| | Age Factors | 2 | 2020 | 3297 | 0.050 |
Why?
| | Epigenomics | 1 | 2022 | 115 | 0.050 |
Why?
| | Genome, Viral | 1 | 2022 | 145 | 0.050 |
Why?
| | Genes, Recessive | 1 | 2021 | 78 | 0.050 |
Why?
| | Inheritance Patterns | 1 | 2021 | 47 | 0.050 |
Why?
| | HLA-A Antigens | 1 | 2021 | 55 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2021 | 46 | 0.040 |
Why?
| | Infant, Newborn | 3 | 2020 | 6054 | 0.040 |
Why?
| | Bronchi | 2 | 2014 | 260 | 0.040 |
Why?
| | Quality Control | 1 | 2021 | 171 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2024 | 455 | 0.040 |
Why?
| | Central America | 1 | 2020 | 24 | 0.040 |
Why?
| | China | 1 | 2021 | 217 | 0.040 |
Why?
| | Models, Statistical | 1 | 2025 | 670 | 0.040 |
Why?
| | Sulfonamides | 1 | 2024 | 512 | 0.040 |
Why?
| | Blood Proteins | 1 | 2022 | 252 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 491 | 0.040 |
Why?
| | Infant | 3 | 2021 | 9451 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 752 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2019 | 21 | 0.040 |
Why?
| | Topography, Medical | 1 | 2019 | 10 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2850 | 0.040 |
Why?
| | Asia, Northern | 1 | 2018 | 1 | 0.040 |
Why?
| | Classification | 1 | 2019 | 20 | 0.040 |
Why?
| | Mongolia | 1 | 2018 | 6 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 1946 | 0.040 |
Why?
| | Animals | 6 | 2024 | 36862 | 0.040 |
Why?
| | Databases, Nucleic Acid | 1 | 2018 | 34 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2020 | 7607 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 64 | 0.040 |
Why?
| | Receptors, Natural Killer Cell | 1 | 2018 | 16 | 0.040 |
Why?
| | Hominidae | 1 | 2019 | 85 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2019 | 151 | 0.040 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2018 | 72 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 574 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 892 | 0.030 |
Why?
| | New York City | 1 | 2017 | 87 | 0.030 |
Why?
| | Altitude | 1 | 2022 | 485 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2024 | 1058 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2018 | 3283 | 0.030 |
Why?
| | Health Equity | 1 | 2019 | 99 | 0.030 |
Why?
| | DNA | 1 | 2024 | 1459 | 0.030 |
Why?
| | Multigene Family | 1 | 2017 | 199 | 0.030 |
Why?
| | DNA, Intergenic | 1 | 2016 | 26 | 0.030 |
Why?
| | Parents | 1 | 2025 | 1357 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1700 | 0.030 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 77 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 2016 | 59 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2014 | 2904 | 0.030 |
Why?
| | Prospective Studies | 3 | 2014 | 7595 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2024 | 2479 | 0.030 |
Why?
| | Residence Characteristics | 1 | 2019 | 356 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2019 | 284 | 0.030 |
Why?
| | Sexism | 1 | 2016 | 61 | 0.030 |
Why?
| | Ligands | 1 | 2018 | 664 | 0.030 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 162 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 940 | 0.030 |
Why?
| | Genetic Testing | 1 | 2018 | 454 | 0.030 |
Why?
| | Placenta | 1 | 2022 | 749 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2025 | 2608 | 0.030 |
Why?
| | HLA-DQ alpha-Chains | 1 | 2014 | 16 | 0.030 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2014 | 21 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2014 | 137 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2019 | 2147 | 0.030 |
Why?
| | San Francisco | 1 | 2013 | 52 | 0.030 |
Why?
| | Mouth | 1 | 2014 | 86 | 0.030 |
Why?
| | HapMap Project | 1 | 2013 | 5 | 0.030 |
Why?
| | HeLa Cells | 1 | 2015 | 637 | 0.030 |
Why?
| | Biomarkers | 1 | 2025 | 4164 | 0.030 |
Why?
| | Africa, Northern | 1 | 2013 | 4 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1594 | 0.030 |
Why?
| | Blood Glucose | 1 | 2023 | 2182 | 0.030 |
Why?
| | Mammography | 1 | 2014 | 152 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1355 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2073 | 0.030 |
Why?
| | Skin Tests | 1 | 2013 | 101 | 0.030 |
Why?
| | Interleukin-13 | 1 | 2014 | 149 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 508 | 0.020 |
Why?
| | Hawaii | 1 | 2012 | 32 | 0.020 |
Why?
| | Th2 Cells | 1 | 2014 | 176 | 0.020 |
Why?
| | Genome, Mitochondrial | 1 | 2012 | 28 | 0.020 |
Why?
| | HLA Antigens | 1 | 2014 | 237 | 0.020 |
Why?
| | Protein Binding | 1 | 2019 | 2225 | 0.020 |
Why?
| | Income | 1 | 2013 | 203 | 0.020 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2012 | 59 | 0.020 |
Why?
| | Markov Chains | 1 | 2012 | 123 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2014 | 436 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2012 | 187 | 0.020 |
Why?
| | Boston | 1 | 2011 | 91 | 0.020 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 19 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 400 | 0.020 |
Why?
| | Insurance, Health | 1 | 2013 | 280 | 0.020 |
Why?
| | Angola | 1 | 2011 | 1 | 0.020 |
Why?
| | Air Pollutants | 1 | 2016 | 427 | 0.020 |
Why?
| | Mozambique | 1 | 2011 | 7 | 0.020 |
Why?
| | Canada | 1 | 2012 | 421 | 0.020 |
Why?
| | Educational Status | 1 | 2013 | 484 | 0.020 |
Why?
| | Africa South of the Sahara | 1 | 2011 | 48 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2012 | 131 | 0.020 |
Why?
| | North America | 1 | 2011 | 313 | 0.020 |
Why?
| | Culture | 1 | 2011 | 127 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 431 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2011 | 313 | 0.020 |
Why?
| | Allergens | 1 | 2013 | 408 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2011 | 195 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6818 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6743 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 818 | 0.020 |
Why?
| | Family | 1 | 2013 | 666 | 0.020 |
Why?
| | Tanzania | 1 | 2008 | 58 | 0.020 |
Why?
| | Logistic Models | 1 | 2013 | 2071 | 0.020 |
Why?
| | Social Behavior | 1 | 2011 | 287 | 0.020 |
Why?
| | Hypersensitivity | 1 | 2011 | 257 | 0.020 |
Why?
| | Inbreeding | 1 | 2007 | 18 | 0.020 |
Why?
| | Linear Models | 1 | 2010 | 846 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2014 | 1274 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2014 | 1501 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3414 | 0.020 |
Why?
| | Transcription Factors | 1 | 2014 | 1720 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2715 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2008 | 597 | 0.020 |
Why?
| | Reproduction | 1 | 2007 | 204 | 0.020 |
Why?
| | Models, Biological | 1 | 2013 | 1773 | 0.020 |
Why?
| | Smoking | 1 | 2012 | 1634 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2836 | 0.010 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2002 | 30 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 2002 | 41 | 0.010 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2002 | 37 | 0.010 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2002 | 45 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 5769 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2002 | 318 | 0.010 |
Why?
| | Mice | 1 | 2013 | 17774 | 0.010 |
Why?
|
|
Gignoux's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|